A citation-based method for searching scientific literature

Petra Frick, Chantal Sellier, Ian R A Mackenzie, Chieh-Yu Cheng, Julie Tahraoui-Bories, Cecile Martinat, R Jeroen Pasterkamp, Johannes Prudlo, Dieter Edbauer, Mustapha Oulad-Abdelghani, Regina Feederle, Nicolas Charlet-Berguerand, Manuela Neumann. Acta Neuropathol Commun 2018
Times Cited: 52



Martine Therrien, Guy A Rouleau, Patrick A Dion, J Alex Parker. PLoS One 2013
Times Cited: 125




List of shared articles



Times cited

Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish.
Zoé Butti, Yingzhou Edward Pan, Jean Giacomotto, Shunmoogum A Patten. Commun Biol 2021
1

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD.
Alexander Schmitz, João Pinheiro Marques, Irina Oertig, Niran Maharjan, Smita Saxena. Front Cell Neurosci 2021
0

RNA-mediated toxicity in C9orf72 ALS and FTD.
Zachary T McEachin, Janani Parameswaran, Nisha Raj, Gary J Bassell, Jie Jiang. Neurobiol Dis 2020
4

C9orf72-associated SMCR8 protein binds in the ubiquitin pathway and with proteins linked with neurological disease.
John L Goodier, Alisha O Soares, Gavin C Pereira, Lauren R DeVine, Laura Sanchez, Robert N Cole, Jose Luis García-Pérez. Acta Neuropathol Commun 2020
6

Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Jessica Root, Paola Merino, Austin Nuckols, Michelle Johnson, Thomas Kukar. Neurobiol Dis 2021
5

Modelling C9orf72-Related Amyotrophic Lateral Sclerosis in Zebrafish.
Gabrielle Fortier, Zoé Butti, Shunmoogum A Patten. Biomedicines 2020
3

C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?
Elke Braems, Bart Swinnen, Ludo Van Den Bosch. Acta Neuropathol 2020
8

BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Esteban Quezada, Claudio Cappelli, Iván Diaz, Nur Jury, Nicholas Wightman, Robert H Brown, Martín Montecino, Brigitte van Zundert. Clin Epigenetics 2021
0

C9ORF72: What It Is, What It Does, and Why It Matters.
Julie Smeyers, Elena-Gaia Banchi, Morwena Latouche. Front Cell Neurosci 2021
1

Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster.
Sophie Layalle, Laetitia They, Sarah Ourghani, Cédric Raoul, Laurent Soustelle. Int J Mol Sci 2021
2

Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia.
Delia Gagliardi, Gianluca Costamagna, Michela Taiana, Luca Andreoli, Fabio Biella, Margherita Bersani, Nereo Bresolin, Giacomo Pietro Comi, Stefania Corti. Ageing Res Rev 2020
1


Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion.
Mirjana Babić Leko, Vera Župunski, Jason Kirincich, Dinko Smilović, Tibor Hortobágyi, Patrick R Hof, Goran Šimić. Behav Neurol 2019
25

Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels.
Shangxi Xiao, Paul M McKeever, Agnes Lau, Janice Robertson. Acta Neuropathol Commun 2019
17

Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72.
Qiang Zhu, Jie Jiang, Tania F Gendron, Melissa McAlonis-Downes, Lulin Jiang, Amy Taylor, Sandra Diaz Garcia, Somasish Ghosh Dastidar, Maria J Rodriguez, Patrick King,[...]. Nat Neurosci 2020
56


The progress in C9orf72 research: ALS/FTD pathogenesis, functions and structure.
Lan Jiang, Tizhong Zhang, Kefeng Lu, Shiqian Qi. Small GTPases 2021
1